CXCL12/CXCR4 promotes inflammation-driven colorectal cancer progression through activation of RhoA signaling by sponging miR-133a-3p

被引：0
|
作者：
Xinfeng Yu
Dong Wang
Xiaohui Wang
Shiyue Sun
Yuhang Zhang
Shuqing Wang
Rongrong Miao
Xiaoxue Xu
Xianjun Qu
机构：
[1] School of Basic Medical Sciences,Department of Pharmacology
[2] Capital Medical University,Department of General Surgery
[3] Xuan Wu Hospital,Department of Central Laboratory
[4] Capital Medical University,undefined
[5] Capital Medical University,undefined
来源：
Journal of Experimental & Clinical Cancer Research | / 38卷
关键词：
CXCR4; RhoA; miR-133a-3p; lncRNA XIST; CAC;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] CXCL12/CXCR4 promotes inflammation-driven colorectal cancer progression through activation of RhoA signaling by sponging miR-133a-3p
    Yu, Xinfeng
    Wang, Dong
    Wang, Xiaohui
    Sun, Shiyue
    Zhang, Yuhang
    Wang, Shuqing
    Miao, Rongrong
    Xu, Xiaoxue
    Qu, Xianjun
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2019, 38 (1)
  • [2] Mechanisms mediated by CXCL12 signaling through CXCR4 and CXCR7 in breast cancer
    Mosley, Lasharon D.
    Singh, Rajesh
    Sharma, Praveen K.
    Triplett, Ashley S.
    Singh, Shailesh
    Lillard, James W.
    CANCER RESEARCH, 2010, 70
  • [3] Inhibition of Abdominal Aortic Aneurysm Progression Through the CXCL12/CXCR4 Axis via MiR206-3p Sponge
    Xuan, Xuezhen
    Li, Yaling
    Cao, Genmao
    Hu, Jie
    Yan, Sheng
    Jin, Haijiang
    Qiao, Maolin
    Zhang, Ruijing
    Dong, Honglin
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2025, 29 (01)
  • [4] Enhanced CXCL12/CXCR4 signaling increases tumor progression in radiation-resistant pancreatic cancer
    Kato, Tomokatsu
    Matsuo, Yoichi
    Ueda, Goro
    Murase, Hiromichi
    Aoyama, Yoshinaga
    Omi, Kan
    Hayashi, Yuichi
    Imafuji, Hiroyuki
    Saito, Kenta
    Morimoto, Mamoru
    Ogawa, Ryo
    Takahashi, Hiroki
    Takiguchi, Shuji
    ONCOLOGY REPORTS, 2022, 47 (04)
  • [5] PTEN loss mediated Akt activation promotes prostate tumor growth via CXCL12/CXCR4 signaling
    Conley-Lacomb, Katie
    Saliganan, Allen
    Chen, Yong Q.
    Kim, Hyeong-Reh C.
    Cher, Michael L.
    Chinni, Sreenivasa
    CANCER RESEARCH, 2013, 73 (08)
  • [6] CXCR4/CXCL12 axis promotes VEGF-mediated tumor angiogenesis through Akt signaling pathway
    Liang, Zhongxing
    Brooks, Joann
    Willard, Margaret
    Liang, Ke
    Yoon, Younghyoun
    Kang, Seunghee
    Shim, Hyunsuk
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2007, 359 (03) : 716 - 722
  • [7] CXCL12/CXCR4 activation by cancer-associated fibroblasts promotes integrin β1 clustering and invasiveness in gastric cancer
    Izumi, Daisuke
    Ishimoto, Takatsugu
    Miyake, Keisuke
    Sugihara, Hidetaka
    Eto, Kojiro
    Sawayama, Hiroshi
    Yasuda, Tadahito
    Kiyozumi, Yuki
    Kaida, Takayoshi
    Kurashige, Junji
    Imamura, Yu
    Hiyoshi, Yukiharu
    Iwatsuki, Masaaki
    Iwagami, Shiro
    Baba, Yoshifumi
    Sakamoto, Yasuo
    Miyamoto, Yuji
    Yoshida, Naoya
    Watanabe, Masayuki
    Takamori, Hiroshi
    Araki, Norie
    Tan, Patrick
    Baba, Hideo
    INTERNATIONAL JOURNAL OF CANCER, 2016, 138 (05) : 1207 - 1219
  • [8] PTEN loss mediated Akt activation promotes prostate tumor growth and metastasis via CXCL12/CXCR4 signaling
    Conley-LaComb, M. Katie
    Saliganan, Allen
    Kandagatla, Pridvi
    Chen, Yong Q.
    Cher, Michael L.
    Chinni, Sreenivasa R.
    MOLECULAR CANCER, 2013, 12
  • [9] PTEN loss mediated Akt activation promotes prostate tumor growth and metastasis via CXCL12/CXCR4 signaling
    M Katie Conley-LaComb
    Allen Saliganan
    Pridvi Kandagatla
    Yong Q Chen
    Michael L Cher
    Sreenivasa R Chinni
    Molecular Cancer, 12
  • [10] Deficiency in Dipeptidyl Peptidase-4 Promotes Chemoresistance Through the CXCL12/CXCR4/mTOR/TGFβ Signaling Pathway in Breast Cancer Cells
    Li, Shaolan
    Fan, Yang
    Kumagai, Asako
    Kawakita, Emi
    Kitada, Munehiro
    Kanasaki, Keizo
    Koya, Daisuke
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (03)
12345